Newsroom

American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Hybrid Conference

Overview

Corporate Profile

Castle Creek Biosciences, Inc., a late-stage cell and gene therapy company, is using lentiviral vector delivery platforms to develop and commercialize gene therapies, initially targeting skin, connective tissue and metabolic diseases. Our scientists use ex vivo and in vivo technologies to switch gene targets and create optimal therapies for a multitude of genetic diseases.

Investors